Liver cancer cells hep g2 cells. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy20

Hep G2 Cells Cell Line, Tumor Liver Tumor Cells, Cultured Hepatocytes Microsomes, Liver Cell Line Mitochondria, Liver HCT116 Cells MCF-7 Cells HT29 Cells Neoplastic Stem Cells Cell Nucleus Hepatic Artery Breast Cells, Cultured Bile Ducts, Intrahepatic Epithelial Cells Prostate Mitochondria

Organisms6

Mice, Nude Mice, SCID Mice, Inbred BALB C Adenoviridae Mice, Transgenic Rats, Inbred F344

Diseases49

Liver Neoplasms Carcinoma, Hepatocellular Liver Neoplasms, Experimental Liver Diseases Breast Neoplasms Liver Cirrhosis Neoplasms Colonic Neoplasms Neoplasm Invasiveness Lung Neoplasms Ovarian Neoplasms Fatty Liver Neoplasm Metastasis Stomach Neoplasms Pancreatic Neoplasms Colorectal Neoplasms Cell Transformation, Neoplastic Disease Progression Drug-Induced Liver Injury Prostatic Neoplasms Cholangiocarcinoma Carcinoma Adenocarcinoma Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Uterine Cervical Neoplasms Hepatoblastoma Disease Models, Animal Carcinoma, Squamous Cell Hepatitis B Genetic Predisposition to Disease Neoplasms, Hormone-Dependent Liver Failure, Acute Neovascularization, Pathologic Liver Abscess Liver Diseases, Alcoholic Bile Duct Neoplasms Neoplasm Recurrence, Local Endometrial Neoplasms Esophageal Neoplasms Neoplasms, Experimental Precancerous Conditions Liver Cirrhosis, Alcoholic Bone Neoplasms Carcinoma, Small Cell Hepatitis Carcinogenesis Mammary Neoplasms, Experimental Rectal Neoplasms

Chemicals and Drugs76

Tocotrienols Antineoplastic Agents Methionine Adenosyltransferase RNA, Messenger RNA, Small Interfering Caspase 3 Caspases Neoplasm Proteins Antineoplastic Agents, Phytogenic Tumor Markers, Biological Tumor Suppressor Protein p53 DNA, Neoplasm Diethylnitrosamine Receptors, Estrogen Transcription Factors RNA, Neoplasm Proto-Oncogene Proteins c-akt Aflatoxin B1 Receptor, erbB-2 MicroRNAs Tumor Suppressor Proteins Anticarcinogenic Agents Cisplatin DNA-Binding Proteins Liver Extracts Hempa Antigens, Neoplasm Cancer Vaccines Tamoxifen Carcinogens Receptor, Epidermal Growth Factor alpha-Fetoproteins Proto-Oncogene Proteins Proto-Oncogene Proteins c-bcl-2 Enzyme Inhibitors beta Catenin Fluorouracil Receptors, Androgen Antibodies, Monoclonal Plant Extracts Paclitaxel Antibiotics, Antineoplastic Antimetabolites, Antineoplastic Androgens Aflatoxins Protein-Serine-Threonine Kinases DNA Primers Carrier Proteins Nuclear Proteins Estrogen Receptor alpha Membrane Proteins DNA Reactive Oxygen Species Cadherins Apoptosis Regulatory Proteins Prostate-Specific Antigen Glycoproteins Cyclin-Dependent Kinase Inhibitor p21 Protein Kinase Inhibitors Phosphatidylinositol 3-Kinases Receptors, Progesterone NF-kappa B Estrogens Recombinant Proteins Doxorubicin Antineoplastic Agents, Hormonal Isoenzymes Thorium Dioxide Proto-Oncogene Proteins c-myc Inhibitor of Apoptosis Proteins Estradiol STAT3 Transcription Factor Cyclooxygenase 2 Ethiodized Oil Estrogen Antagonists Propyl Gallate

Analytical, Diagnostic and Therapeutic Techniques and Equipment53

Liver Neoplasms, Experimental Reverse Transcriptase Polymerase Chain Reaction Blotting, Western Xenograft Model Antitumor Assays Liver Transplantation Inhibitory Concentration 50 Early Detection of Cancer Transfection Neoplasm Transplantation Drug Screening Assays, Antitumor Liver Function Tests Gene Expression Profiling Transplantation, Heterologous Hepatectomy Prognosis Gene Knockdown Techniques Immunohistochemistry Flow Cytometry Survival Rate Tumor Burden Oligonucleotide Array Sequence Analysis Survival Analysis Retrospective Studies Antineoplastic Combined Chemotherapy Protocols Risk Factors Follow-Up Studies Disease Models, Animal Risk Models, Biological Neoplasm Staging Registries Genetic Therapy Real-Time Polymerase Chain Reaction Molecular Targeted Therapy Risk Assessment Prospective Studies Incidence Combined Modality Therapy Treatment Outcome Sensitivity and Specificity Immunoenzyme Techniques Odds Ratio Drug Delivery Systems Neoplasms, Experimental Blotting, Northern Kaplan-Meier Estimate Immunoblotting Disease-Free Survival Polymerase Chain Reaction Tumor Stem Cell Assay Reproducibility of Results Mammary Neoplasms, Experimental Multivariate Analysis

Phenomena and Processes51

Apoptosis Gene Expression Regulation, Neoplastic Cell Proliferation Cell Survival Down-Regulation Signal Transduction Cell Division Dose-Response Relationship, Drug Inhibitory Concentration 50 Promoter Regions, Genetic Liver Regeneration Drug Resistance, Neoplasm DNA Fragmentation Enzyme Activation Transfection Cell Movement Cell Cycle RNA Interference Base Sequence Cell Growth Processes Up-Regulation Gene Expression Mutation Time Factors Transcription, Genetic Drug Synergism Gene Silencing Phosphorylation Liver Circulation Risk Kinetics Genetic Predisposition to Disease Epithelial-Mesenchymal Transition Genes, Tumor Suppressor Cell Adhesion Phenotype Protein Binding Amino Acid Sequence Gene Expression Regulation Cell Death Sensitivity and Specificity Genes, p53 Odds Ratio DNA Damage Genetic Vectors DNA Methylation Gene Expression Regulation, Enzymologic Autophagy Epigenesis, Genetic Tissue Distribution Transcriptional Activation

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Information Science6

Base Sequence Molecular Sequence Data Survival Rate Registries Incidence Amino Acid Sequence

Health Care19

Survival Rate Survival Analysis Retrospective Studies Risk Factors Follow-Up Studies Risk Registries Risk Assessment Prospective Studies Incidence Age Factors Treatment Outcome Sensitivity and Specificity Odds Ratio National Cancer Institute (U.S.)Kaplan-Meier Estimate Disease-Free Survival Reproducibility of Results Multivariate Analysis

Geographicals3

China Japan United States

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care Geographicals

Liver Neoplasms Carcinoma, Hepatocellular Hep G2 Cells Cell Line, Tumor Tocotrienols Liver Neoplasms, Experimental Apoptosis Gene Expression Regulation, Neoplastic Liver Cell Proliferation Antineoplastic Agents Tumor Cells, Cultured Mice, Nude Liver Diseases Methionine Adenosyltransferase Cell Survival RNA, Messenger Reverse Transcriptase Polymerase Chain Reaction Breast Neoplasms Blotting, Western Xenograft Model Antitumor Assays RNA, Small Interfering Liver Cirrhosis Liver Transplantation Down-Regulation Hepatocytes Signal Transduction Cell Division Dose-Response Relationship, Drug Inhibitory Concentration 50 Caspase 3 Promoter Regions, Genetic Caspases Neoplasms Colonic Neoplasms Neoplasm Invasiveness Liver Regeneration Lung Neoplasms Ovarian Neoplasms Fatty Liver Neoplasm Metastasis Microsomes, Liver Early Detection of Cancer Drug Resistance, Neoplasm DNA Fragmentation Stomach Neoplasms Pancreatic Neoplasms Enzyme Activation Neoplasm Proteins Transfection Neoplasm Transplantation Drug Screening Assays, Antitumor Cell Movement Cell Cycle Liver Function Tests Gene Expression Profiling Antineoplastic Agents, Phytogenic Transplantation, Heterologous Cell Line RNA Interference Tumor Markers, Biological Base Sequence Cell Growth Processes Tumor Suppressor Protein p53 Mitochondria, Liver Colorectal Neoplasms Cell Transformation, Neoplastic Molecular Sequence Data Up-Regulation Hepatectomy HCT116 Cells Disease Progression MCF-7 Cells Prognosis Drug-Induced Liver Injury HT29 Cells Prostatic Neoplasms Cholangiocarcinoma Gene Expression Gene Knockdown Techniques Neoplastic Stem Cells Immunohistochemistry Mutation Time Factors Transcription, Genetic Drug Synergism Carcinoma Gene Silencing DNA, Neoplasm Adenocarcinoma Phosphorylation Flow Cytometry Diethylnitrosamine Survival Rate Liver Circulation Receptors, Estrogen Transcription Factors Mice, SCID RNA, Neoplasm Mice, Inbred BALB C

No FAQ available that match "liver cancer cells hep g2 cells"